Ipilimumab versus placebo after complete resection of stage III melanoma: Initial efficacy and safely results from the EORTC 18071 phase III trial / Ascierto, P. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - 32:15(2014).

Ipilimumab versus placebo after complete resection of stage III melanoma: Initial efficacy and safely results from the EORTC 18071 phase III trial

Ascierto P
2014

2014
Ipilimumab versus placebo after complete resection of stage III melanoma: Initial efficacy and safely results from the EORTC 18071 phase III trial / Ascierto, P. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - 32:15(2014).
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/1014382
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1349
  • ???jsp.display-item.citation.isi??? ND
social impact